Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32359490

Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2020 May
First author
Ledermann JA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 May;21(5):616-617. doi: 10.1016/S1470-2045(20)30079-6.
    note
    Source null
    related pmid
    32359486
    relationship
    Comment in

Authors and identifiers

  1. name
    Ledermann JA
    type
    Author
  2. name
    Oza AM
    type
    Author
  3. name
    Lorusso D
    type
    Author
  4. name
    Aghajanian C
    type
    Author
  5. name
    Oaknin A
    type
    Author
  6. name
    Dean A
    type
    Author
  7. name
    Colombo N
    type
    Author
  8. name
    Weberpals JI
    type
    Author
  9. name
    Clamp AR
    type
    Author
  10. name
    Scambia G
    type
    Author
  11. name
    Leary A
    type
    Author
  12. name
    Holloway RW
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Ledermann JA
    type
    Author
  2. name
    Oza AM
    type
    Author
  3. name
    Lorusso D
    type
    Author
  4. name
    Aghajanian C
    type
    Author
  5. name
    Oaknin A
    type
    Author
  6. name
    Dean A
    type
    Author
  7. name
    Colombo N
    type
    Author
  8. name
    Weberpals JI
    type
    Author
  9. name
    Clamp AR
    type
    Author
  10. name
    Scambia G
    type
    Author
  11. name
    Leary A
    type
    Author
  12. name
    Holloway RW
    type
    Author
bibliography ids
  1. nci-bib-e8aa6f5efc2d4d56adc4fbc9
book metadata
content sha256
96664783527d0ef25d8557491a9f2f8da7709b53001b347b454db8a7fd27ada3
document type
citation
dois
  1. 10.1016/S1470-2045(20)30061-9
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:32359490
immutable id
pubmed:32359490@96664783527d0ef25d8557491a9f2f8da7709b53001b347b454db8a7fd27ada3
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
5
name
The Lancet. Oncology
nlm unique id
100957246
pages
710-722
volume
21
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 May;21(5):616-617. doi: 10.1016/S1470-2045(20)30079-6.
    note
    Source null
    related pmid
    32359486
    relationship
    Comment in
outcomes validated
false
pmid
32359490
provenance
batch id
40d9eae1f1d369f13109
provider
NCBI PubMed ESummary
record sha256
69d7030558c9ab45785a322f331f0c3d7ddfa771b8703e8d068035511846eaa5
response sha256
03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
retrieved at
2026-09-09T23:47:52.637547+00:00
publication date
display
2020 May
precision
month
year
2020
publication types
  1. Journal Article
  2. Research Support, N.I.H., Extramural
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32359490/
title
Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial.

Preserved source evidence · Not medical advice